论文部分内容阅读
1 抗肿瘤药FDA批准 Zom eta上市 美国 FDA已批准诺华公司的静注用二膦酸盐类药物 Zometa(通用名 :佐膦酸 ,zoledronicacid)上市。该药用于治疗恶性高钙血症 (HCM)。诺华公司预计该药在一个月后投放市场。作为美国罕见病用药 ,该药的这一适应证已在包括欧共体在内的三十多个国
1 Antineoplastic FDA Approves Zom eta for Market Listing The U.S. FDA has approved Novartis’ intravenous injection of the Zometa (generic name: zoledronic acid) bisphosphonate. This medicine is used to treat malignant hypercalcemia (HCM). Novartis expects the drug to be on the market in a month. As a rare disease drug in the United States, this indication of the drug has been used in over 30 countries, including the European Community